![]() ![]() Following a second review by the Board of Directors, one of the items was replaced with an alternate item from the short list. Literature reviews were conducted for the five Choosing Wisely items selected by the Board and the group drafted verbiage, bullet points and references for each item. Based on the survey results, the work group submitted a short list of eight items to the ASTRO Board of Directors, from which the Board chose five items to move forward. The survey also included an open text box for members to comment on the suggested items and to provide additional ideas for Choosing Wisely items. Next, an electronic anonymous survey was sent to the ASTRO membership to rate the value and relevancy of each of the items. The work group began by narrowing a list of 28 draft concepts to nine potential Choosing Wisely items. ASTRO’s disclosure and conflict of interest policy can be found at: 6–10: In January 2014, the American Society for Radiation Oncology (ASTRO) formed a group to develop its second Choosing Wisely list, which included representatives from health policy, government relations, and clinical affairs and quality. The final items for submission were selected by ASTRO’s Board of Directors. A literature review was conducted for each topic by ASTRO staff and each work group member took the lead on writing text and selecting references for one or more draft items. Three conference calls were subsequently held to further refine the list and finalize the wording of the items based on input from ASTRO’s Board of Directors. The results were tabulated and a list of the highest scoring items generated, creating a short list of 13 draft items. The work group members were asked to pick their top eight items from the total of 34 topics that had been suggested in the initial survey. A work group, comprised of seven physicians drawn from these three areas, was also selected and convened. Patients with any specific questions about the items on this list or their individual situation should consult their physician.ġ–5: Following approval of the participation of the American Society for Radiation Oncology (ASTRO) in the Choosing Wisely campaign, a survey was sent to ASTRO committees and panels related to health policy, government relations, and clinical affairs and quality in order to identify potential items for inclusion in the list. These items are provided solely for informational purposes and are not intended as a substitute for consultation with a medical professional. Financial toxicity has been observed to be associated with reduced treatment compliance and lower overall survival.Heavy financial burdens can accrue, sometimes to the point of financial insolvency. Radiation treatment decisions, including implemented technology, fractionation regimen, and whether radiation can be omitted, all may meaningfully influence the financial impact of the treatment on the patient.Cancer patients are at high risk for financial hardships due to lost productivity and uncovered treatment expenses.View all recommendations from this societyĭo not routinely initiate radiation therapy, or other forms of cancer treatment, without consideration of potential financial toxicity to patients. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |